CL2022001033A1 - Método para preparar aril 2-tetrazol-2-il cetona con selectividad mejorada - Google Patents

Método para preparar aril 2-tetrazol-2-il cetona con selectividad mejorada

Info

Publication number
CL2022001033A1
CL2022001033A1 CL2022001033A CL2022001033A CL2022001033A1 CL 2022001033 A1 CL2022001033 A1 CL 2022001033A1 CL 2022001033 A CL2022001033 A CL 2022001033A CL 2022001033 A CL2022001033 A CL 2022001033A CL 2022001033 A1 CL2022001033 A1 CL 2022001033A1
Authority
CL
Chile
Prior art keywords
tetrazol
ketone
improved selectivity
preparing aryl
aryl
Prior art date
Application number
CL2022001033A
Other languages
English (en)
Inventor
Kyu Woong Lee
Yyung Mi Cha
Su Yeon Yeom
Ji Seon Woo
Original Assignee
Sk Biopharmaceuticals Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US16/662,547 external-priority patent/US10611737B1/en
Application filed by Sk Biopharmaceuticals Co Ltd filed Critical Sk Biopharmaceuticals Co Ltd
Publication of CL2022001033A1 publication Critical patent/CL2022001033A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

La presente descripción se relaciona a un método para preparar aril 2-tetrazol-2-il cetona de la Fórmula 1a con selectividad mejorada.
CL2022001033A 2019-10-24 2022-04-22 Método para preparar aril 2-tetrazol-2-il cetona con selectividad mejorada CL2022001033A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16/662,547 US10611737B1 (en) 2019-10-24 2019-10-24 Method for preparing aryl 2-tetrazol-2-yl ketone with improved selectivity
KR20190133120 2019-10-24

Publications (1)

Publication Number Publication Date
CL2022001033A1 true CL2022001033A1 (es) 2022-11-11

Family

ID=75619913

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2022001033A CL2022001033A1 (es) 2019-10-24 2022-04-22 Método para preparar aril 2-tetrazol-2-il cetona con selectividad mejorada

Country Status (12)

Country Link
EP (1) EP4048658A4 (es)
JP (1) JP2022553754A (es)
KR (1) KR20220087475A (es)
CN (2) CN118221604A (es)
AU (1) AU2020371025A1 (es)
BR (1) BR112022007120A2 (es)
CA (1) CA3154266A1 (es)
CL (1) CL2022001033A1 (es)
IL (1) IL292389A (es)
MX (1) MX2022004740A (es)
WO (1) WO2021080380A1 (es)
ZA (1) ZA202203822B (es)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58140083A (ja) * 1982-02-15 1983-08-19 Chisso Corp テトラゾ−ル類の製造方法
BRPI0924997B1 (pt) * 2009-06-22 2024-01-16 Sk Biopharmaceuticals Co., Ltd Método para preparar um composto de éster do ácido 1-aril-2- tetrazoil etil carbâmico
US8404461B2 (en) * 2009-10-15 2013-03-26 SK Biopharmaceutical Co. Ltd. Method for preparation of carbamic acid (R)-1-aryl-2-tetrazolyl-ethyl ester

Also Published As

Publication number Publication date
EP4048658A4 (en) 2024-02-21
CN114901647A (zh) 2022-08-12
KR20220087475A (ko) 2022-06-24
MX2022004740A (es) 2022-05-16
CN114901647B (zh) 2024-04-02
BR112022007120A2 (pt) 2022-07-05
EP4048658A1 (en) 2022-08-31
CA3154266A1 (en) 2021-04-29
JP2022553754A (ja) 2022-12-26
AU2020371025A1 (en) 2022-04-21
CN118221604A (zh) 2024-06-21
ZA202203822B (en) 2024-08-28
WO2021080380A1 (en) 2021-04-29
IL292389A (en) 2022-06-01

Similar Documents

Publication Publication Date Title
CL2021000630A1 (es) Métodos para producir un anticuerpo anti-c5 (divisional de la solicitud no. 201701585)
MX2016016297A (es) Procedimientos para la preparacion de compuestos antivirales.
BR112017006253A2 (pt) novos compostos
AR116790A1 (es) PROCEDIMIENTO PARA LA PREPARACIÓN DE 3a-HIDROXI-5a-PREGNAN-20-ONA (BREXANOLONA)
EA201992183A2 (ru) Синтез полициклических карбамоилпиридоновых соединений
CL2020003254A1 (es) Procedimiento para la deshidratación de agua fangosa acuosa
EA201790983A1 (ru) Синтез копанлисиба и его дигидрохлорида
EA201992421A1 (ru) Способ получения озанимода
EA201891769A1 (ru) СПОСОБ ПОЛУЧЕНИЯ СОЕДИНЕНИЯ ПИРРОЛО[3,2-d]ПИРИМИДИНА И ПРОМЕЖУТОЧНЫХ СОЕДИНЕНИЙ
EA201991241A1 (ru) Способ получения метоксиметилпиридин дикарбоксилата
BR112016025024A2 (pt) ?processo para preparar compostos ceto, e, uso de farnesil acetona?
CL2018002756A1 (es) Un proceso mejorado para la preparación de tartrato de butorfanol.
MX2019001465A (es) Metodo de produccion de cetoenoles ciclicos sustituidos con espirocetales.
WO2015120111A3 (en) Expedient synthesis of sitagliptin
CL2021003459A1 (es) Método para producir hidróxido de litio.
AR098879A1 (es) Síntesis de ent-progesterona y sus productos intermedios
BR112016022437A2 (pt) Processo para preparação de (2s,5r)-6-(benziloxi)-7-oxo-1,6- diazabiciclo[3,2,1]octano-2-carboxilato de sódio
BR112016016397A2 (pt) método para preparar 1-alquil-3-difluorometil-5-fluoro-1h-pirazol-4-carbaldeídos e 1-alquil-3-difluorometil-5-fluoro-1h-pirazol-4-carboxilatos.
AR101951A1 (es) Síntesis de ent-progesterona e intermediarios de la misma
CL2022001033A1 (es) Método para preparar aril 2-tetrazol-2-il cetona con selectividad mejorada
BR112019002828A2 (pt) método de preparação de derivados de estireno substituído
BR112018072675A2 (pt) método para produzir derivados de 1-h-pirrolidina-2,4-diona espirocíclicos substituídos por cis-alcóxi
CL2021000902A1 (es) Método para la fabricación de gemas sintéticas.
CL2021000663A1 (es) Proceso para la producción de gas de síntesis.
MX2019000984A (es) Proceso para preparacion de indanonas.